Form 8-K - Current report:
SEC Accession No. 0001437749-25-029846
Filing Date
2025-09-25
Accepted
2025-09-25 08:01:53
Documents
16
Period of Report
2025-09-25
Items
Item 7.01: Regulation FD Disclosure
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K clnn20250923_8k.htm   iXBRL 8-K 31338
2 EXHIBIT 99.1 ex_863758.htm EX-99.1 1557
3 EXHIBIT 99.2 ex_863757.htm EX-99.2 23023
8 slide1.jpg GRAPHIC 479819
  Complete submission text file 0001437749-25-029846.txt   876197

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA clnn-20250925.xsd EX-101.SCH 4124
5 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE clnn-20250925_def.xml EX-101.DEF 13920
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE clnn-20250925_lab.xml EX-101.LAB 18405
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE clnn-20250925_pre.xml EX-101.PRE 13952
18 EXTRACTED XBRL INSTANCE DOCUMENT clnn20250923_8k_htm.xml XML 5086
Mailing Address 6550 SOUTH MILLROCK DRIVE, SUITE G50 SALT LAKE CITY UT 84121
Business Address 6550 SOUTH MILLROCK DRIVE, SUITE G50 SALT LAKE CITY UT 84121 801-676-9695
Clene Inc. (Filer) CIK: 0001822791 (see all company filings)

EIN.: 852828339 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39834 | Film No.: 251340250
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)